In answer to the question my colleague Nikki Sein posed, “Can things get worse for the cruise ship industry?” If Costa Cruises’ most recent debacle is any indication, the answer [...]
Business viewpoints from the editors at Hoover's
In answer to the question my colleague Nikki Sein posed, “Can things get worse for the cruise ship industry?” If Costa Cruises’ most recent debacle is any indication, the answer [...]
May 22, 2013
Pfizer today announced its intention to split off its remaining interest — some 80 percent — in Zoetis. Formerly Pfizer’s animal health business, Zoetis completed its initial public offering in February 2013. Pfizer is distributing its remaining stake in Zoetis so it can slim down its operations and focus on its core biopharmaceutical business. Zoetis makes drugs and vaccines given to animals, and sells its products directly to livestock producers and veterinarians in 70 countries.
Computer Manufacturers See Opportunity in China
How to Use Third Party Data to Build Customer Relationships
Warming Up to the Cold Call
How to Prepare for a Sales Call
Email marketing: Keep mobile in mind
How to write email that customers will actually read
The evolution of sales intelligence and social CRM
Choosing an email marketing service provider
Hoover’s company descriptions put insight at your fingertips
Copyright © 2012 All Rights Reserved
Recent Comments